Ventriculoperitoneal shunt surgery (VP shunt surgery) is the standard surgical treatment for primary and secondary hydrocephalus across pediatric and adult populations. Cerebrospinal fluid (CSF) is continuously produced by the choroid plexus inside the brain ventricles at a rate of approximately 0.35 milliliters per minute. In healthy individuals, CSF circulates around the brain and spinal cord before being absorbed into the venous bloodstream. When an obstruction, absorption defect, or overproduction disrupts this pathway, fluid accumulates, elevating intracranial pressure (ICP). Left untreated, high ICP causes brain tissue ischemia, herniation, irreversible cognitive decline, and vision loss. VP shunt surgery restores fluid balance by creating a alternative anatomical pathway, redirecting excess fluid to the peritoneal cavity where it is absorbed across the peritoneal membrane back into the vascular system. Clinical management relies on multidisciplinary care involving neurosurgeons, neurologists, radiographers, and rehabilitation specialists to ensure long-term device function and neurological protection.

VP shunt surgery is performed under general anesthesia in a operating room setting under strict sterile conditions. The patient is placed in a supine position with the head turned to expose the selected cranial entry site, typically the parietal cortex (Keen's point or Dandy's point) or frontal cortex (Kocher's point). The surgical area extending behind the ear, along the lateral neck and chest, down to the abdomen is prepped and draped.

Step 1: Cranial Access and Ventricular Catheterization. The neurosurgeon makes a small curved incision behind the hairline or ear and performs a burr hole opening through the skull bone. The underlying dura mater is incised, and a thin, flexible ventricular catheter guided by anatomical landmarks, stereotactic navigation, or ultrasound is advanced through the brain parenchyma into the lateral ventricle. Free flow of clear cerebrospinal fluid verifies correct placement.

Step 2: Valve Placement and Subcutaneous Tunneling. The proximal catheter is attached to an inline one-way valve system, which sits in a small subcutaneous pocket created behind the ear. A long subcutaneous tunneling tool (passer) is then pushed carefully under the skin from the scalp incision, extending down the neck and anterior chest wall to a second small incision in the upper abdominal wall.

Step 3: Peritoneal Insertion. The distal shunt tubing is pulled through the subcutaneous tunnel and connected to the valve outlet. The neurosurgeon then opens the abdominal cavity via a small laparotomy incision or uses laparoscopic visualization to introduce the distal end of the catheter into the peritoneal cavity, where fluid reabsorption occurs naturally across the peritoneum.

Step 4: Verification and Closure. The surgeon confirms unobstructed CSF flow through the whole assembly. Surgical incisions are irrigated with antibiotic solution and closed in multiple anatomical layers using absorbable sutures and skin staples or surgical glue. Sterile dressings are applied.

VP shunt surgery offers well-established, life-saving clinical benefits supported by decades of neurosurgical evidence:

• Reduction of Intracranial Pressure: Rapidly lowers dangerous elevations in brain pressure, averting brain tissue herniation and secondary ischemic injury.
• Resolution of Neurological Symptoms: Alleviates acute pressure symptoms such as severe headache, nausea, persistent vomiting, double vision (diplopia), and papilledema.
• Functional Gait and Cognitive Improvement in INPH: Clinical trials confirm that up to 80% of properly selected INPH patients experience substantial recovery in walking velocity, balance, and cognitive function (Relkin et al., 2005).
• Prevention of Progressive Brain Injury: In pediatric hydrocephalus, timely shunt insertion preserves cortical mantle thickness, supporting motor, language, and cognitive development.
• Long-Term Non-Invasive Adjustability: Modern programmable valve systems permit external, non-invasive adjustments to drainage settings without repeat surgical operations.

Recovery following VP shunt surgery progresses across distinct physiological phases over several weeks to months:

• Inpatient Phase (Days 1–4): Focuses on post-anesthesia stabilization, pain control, surgical wound care, and early mobilization. Head elevation at 30 degrees is maintained initially to prevent rapid CSF drainage. Neurological assessments are conducted every 2 to 4 hours.
• Early Home Recovery (Weeks 1–2): Incisions behind the ear, on the neck/chest, and over the abdomen must remain clean and dry. Patients engage in gentle walking while avoiding bending, twisting, heavy lifting (>5 kg), or straining. Mild headaches and abdominal discomfort are common and managed with prescribed oral analgesics.
• Intermediate Recovery (Weeks 3–6): Most routine daily activities can be resumed. Staples or non-absorbable skin sutures are removed between days 10 and 14 if applicable. Patients may return to non-strenuous sedentary work or school, pending neurosurgical clearance. Driving is restricted until cognitive, visual, and motor functions fully recover and regulatory clearance is granted.
• Long-Term Maintenance (Months 3 and beyond): Ongoing surveillance involves baseline neuroimaging (CT or MRI) at 3 to 6 months post-surgery, followed by routine annual or bi-annual clinical follow-up. Patients resume full normal physical activities, though contact sports requiring heavy helmet contact or high impact are generally advised against due to risk of hardware dislodgement.

VP shunt surgery is indicated for disorders characterized by impaired cerebrospinal fluid dynamics, including:

• Congenital hydrocephalus resulting from neural tube defects, aqueductal stenosis, or congenital malformations such as Chiari malformation and Dandy-Walker syndrome.
• Acquired hydrocephalus secondary to intracranial hemorrhage (e.g., intraventricular hemorrhage in neonates or subarachnoid hemorrhage in adults).
• Post-traumatic hydrocephalus developing after severe traumatic brain injury.
• Post-infectious hydrocephalus arising as a complication of bacterial or viral meningitis.
• Obstructive hydrocephalus caused by intraventricular or extraventricular space-occupying lesions, such as brain tumors, colloid cysts, or posterior fossa masses.
• Idiopathic normal pressure hydrocephalus (INPH), a progressive neurodegenerative condition affecting older adults characterized by gait instability, cognitive decline, and urinary incontinence.
• Pseudotumor cerebri (idiopathic intracranial hypertension) in refractory cases failing medical management or optic nerve sheath fenestration.

Preoperative preparation for VP shunt surgery includes comprehensive clinical and imaging evaluations. Patients undergo brain imaging via MRI or CT to map ventricular anatomy and identify any structural obstructions. Basic laboratory testing involves complete blood count, electrolyte panel, renal function testing, and coagulation profiles (PT/INR, PTT) to ensure safe surgical hemostasis. Medications that inhibit blood clotting, such as antiplatelet agents (aspirin, clopidogrel) and anticoagulants (warfarin, direct oral anticoagulants), must be held under medical supervision for 3 to 7 days prior to surgery. Patients are instructed to fast (NPO) for 8 hours before general anesthesia. Antiseptic body wash (chlorhexidine) may be prescribed for bathing the evening before and morning of the procedure to lower skin bacterial colonization and reduce surgical site infection risks.

VP shunt surgery carries specific surgical, mechanical, and infectious risks categorized by clinical severity. Minor or transient risks include localized wound soreness, mild abdominal discomfort, skin bruising along the subcutaneous catheter tunnel, and transient postural headaches. Moderate complications include catheter misplacement requiring early surgical revision, localized wound breakdown, or mechanical blockage of the peritoneal tubing by omental tissue or debris. Severe, potentially life-threatening risks include bacterial shunt infection (most commonly Staphylococcus epidermidis or Staphylococcus aureus), which occurs in 5% to 10% of cases and often necessitates total shunt removal, temporary external ventricular drainage, and systemic antibiotic therapy. Additional serious risks include intracerebral hemorrhage during catheter insertion, over-drainage resulting in subdural hematoma or hygroma, severe under-drainage leading to recurrent intracranial hypertension, abdominal CSF pseudocyst formation, bowel perforation during peritoneal insertion, and hardware migration or mechanical fracture over long-term follow-up.

The clinical journey for VP shunt surgery begins with a comprehensive diagnostic evaluation, including magnetic resonance imaging (MRI) or computed tomography (CT) scans, combined with neurological assessments to quantify ventricular enlargement and measure intracranial pressure. Patients undergo routine preoperative cardiac, pulmonary, and blood clearance tests. On the day of surgery, general anesthesia is administered, and the surgical team places the three primary shunt components: an intraventricular catheter inserted through a small cranial opening (burr hole), an adjustable or fixed inline pressure valve placed under the scalp behind the ear, and a distal subcutaneous catheter tunneled under the skin down into the peritoneal cavity. The surgical duration typically ranges from 60 to 90 minutes. Postoperatively, patients spend 24 to 48 hours in a high-dependency or neurosurgical unit for continuous neurological monitoring, head elevation, and surgical wound observation. Total inpatient hospital stay averages 2 to 4 days. Recovery involves gradual mobilization over 2 to 4 weeks, with long-term follow-up including periodic clinical assessments, non-invasive valve adjustments using external magnetic programmers, and imaging to monitor ventricular size and hardware integrity.